Intellectual Property Challenges in the Bio-Pharmaceutical Field By Mike Mireles on Wednesday, May 04, 2016 biotechnology couzzo speed technologies dri capital inter partes review myriad patents pharmaceuticals price regulation royalty pharma securitization +
A Myriad of Problems: Genetic Patents Refused by High Court of Australia By Jani Ihalainen on Friday, October 16, 2015 Australia genetics high court myriad patents +
The New USPTO Interim Guidance on Patent Subject Matter Eligibility By Suleman Ali on Thursday, January 01, 2015 Alice bilski eligibility of patent matter Mayo myriad patentability of diagnostics patentability of software USPTO Guidance +
Myriad: does it make a difference in the real world? By Jeremy on Tuesday, June 18, 2013 Jeremy Phillips myriad patentability United States +
News Flasche: Myriad ruling now out By Jeremy on Thursday, June 13, 2013 DNA Jeremy Phillips myriad patentability United States +
Patentability of Isolated DNA: A Myriad of Analogies By Kate Manning on Tuesday, September 04, 2012 DNA federal circuit Mayo v. Prometheus myriad patents +
Does patenting alienate customers? 23andme gets first US patent. By Darren Smyth on Monday, June 11, 2012 23andme diagnostic method myriad Parkinson's Disease personalised medicine Prometheus +
Letter from AmeriKat: 8,000,000, 3, 1970s, 1, $3,340, #24 - US IP News in Numbers By Annsley Merelle Ward on Monday, August 29, 2011 AmeriKat brand reputation cafc fashion law myriad patenting genes plant variety protection us invalidity us patents US trade mark infringement USPTO +